Studie
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial
PRIMÄR
Tier 1
2019
StudiedesignPRIMÄR
TierTier 1, Human RCT on the exact molecule
År2019
TidskriftCirculation
N3
Tillagd i NO1GEVITYmaj 8, 2026
Citerad av
1 encyklopediartiklar refererar till denna studie.